Pharma company executives debate drug pricing increases
January 12, 2017 at 14:45 PM EST
SAN FRANCISCO Jan 12 (Reuters) - Grappling with a backlash against high U.S. prescription drug prices, more pharmaceutical companies are pledging to limit annual increases to under 10 percent - but the tactic is doing little to salve critics, including President-elect Donald Trump, who on Wednesday said drugmakers are "getting away with murder."